Other
Long-term debt, gross
West Pharmaceutical Services Long-term debt, gross remained flat by 0.0% to $203.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $203.00M to $203.00M. Over 5 years (FY 2020 to FY 2025), Long-term debt, gross shows a downward trend with a -4.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ2 2025
Last reportedQ1 2026
How to read this metric
A decrease indicates deleveraging, which generally reduces financial risk, while an increase may signal expansion or acquisition financing.
Detailed definition
This represents the total principal amount of long-term debt obligations carried on the balance sheet, excluding short-t...
Peer comparison
Standard metric for all capital-intensive firms; essential for calculating debt-to-equity and net debt ratios.
Metric ID:
other_debt_instrument_carrying_amountHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $254.60M | $254.60M | $253.50M | $252.90M | $252.40M | $209.80M | $209.20M | $208.60M | $208.10M | $207.50M | $207.00M | $206.40M | $205.90M | $203.00M | $203.00M | $203.00M | $203.00M | $203.00M | $203.00M | $203.00M |
| QoQ Change | — | +0.0% | -0.4% | -0.2% | -0.2% | -16.9% | -0.3% | -0.3% | -0.2% | -0.3% | -0.2% | -0.3% | -0.2% | -1.4% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -0.9% | -17.6% | -17.5% | -17.5% | -17.6% | -1.1% | -1.1% | -1.1% | -1.1% | -2.2% | -1.9% | -1.6% | -1.4% | +0.0% | +0.0% | +0.0% |
Range$203.00M – $254.60M
CAGR-4.7%
Avg YoY Growth-5.2%
Median YoY Growth-1.3%
Current Streak6 quarters growth
Long-term debt, gross at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's long-term debt, gross?
- West Pharmaceutical Services (WST) reported long-term debt, gross of $203.00M in Q1 2026.
- How has West Pharmaceutical Services's long-term debt, gross changed year-over-year?
- West Pharmaceutical Services's long-term debt, gross decreased by 0.0% year-over-year, from $203.00M to $203.00M.
- What is the long-term trend for West Pharmaceutical Services's long-term debt, gross?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's long-term debt, gross has grown at a -4.5% compound annual growth rate (CAGR), from $255.70M to $203.00M.
- What does long-term debt, gross mean?
- The total amount of long-term debt the company owes to creditors.